S1P defects cause a new entity of cataract, alopecia, oral mucosal disorder, and psoriasis-like syndrome

EMBO Mol Med. 2022 May 9;14(5):e14904. doi: 10.15252/emmm.202114904. Epub 2022 Apr 1.

Abstract

In this report, we discovered a new entity named cataract, alopecia, oral mucosal disorder, and psoriasis-like (CAOP) syndrome in two unrelated and ethnically diverse patients. Furthermore, patient 1 failed to respond to regular treatment. We found that CAOP syndrome was caused by an autosomal recessive defect in the mitochondrial membrane-bound transcription factor peptidase/site-1 protease (MBTPS1, S1P). Mitochondrial abnormalities were observed in patient 1 with CAOP syndrome. Furthermore, we found that S1P is a novel mitochondrial protein that forms a trimeric complex with ETFA/ETFB. S1P enhances ETFA/ETFB flavination and maintains its stability. Patient S1P variants destabilize ETFA/ETFB, impair mitochondrial respiration, decrease fatty acid β-oxidation activity, and shift mitochondrial oxidative phosphorylation (OXPHOS) to glycolysis. Mitochondrial dysfunction and inflammatory lesions in patient 1 were significantly ameliorated by riboflavin supplementation, which restored the stability of ETFA/ETFB. Our study discovered that mutations in MBTPS1 resulted in a new entity of CAOP syndrome and elucidated the mechanism of the mutations in the new disease.

Keywords: CAOP; MBTPS1; electron transfer flavoprotein; mitochondrial respiratory chain reaction.

Publication types

  • Case Reports

MeSH terms

  • Alopecia / genetics
  • Cataract* / genetics
  • Electron-Transferring Flavoproteins / genetics
  • Electron-Transferring Flavoproteins / metabolism
  • Humans
  • Psoriasis*
  • Riboflavin / metabolism

Substances

  • Electron-Transferring Flavoproteins
  • Riboflavin